166 related articles for article (PubMed ID: 38268382)
1. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
2. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
4. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and factors associated with oral potentially malignant disorders and oral squamous cell carcinoma: An institutional study.
Shah JS; Dubey J
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S536-S544. PubMed ID: 38384016
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
8. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.
Sarkis SA; Abdullah BH; Abdul Majeed BA; Talabani NG
Head Neck Oncol; 2010 Jun; 2():13. PubMed ID: 20579333
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma.
Qian L; Qian B; Xu J; Yang J; Wu G; Zhao Y; Liu Q; Yuan Z; Fan Y; Li H
BMC Oral Health; 2023 Apr; 23(1):200. PubMed ID: 37013557
[TBL] [Abstract][Full Text] [Related]
12. Lipid droplets' functional protein caveolin-2 is associated with lipid metabolism-related molecule FABP5 and EMT marker E-cadherin in oral epithelial dysplasia.
Chen XJ; Bai YT; Xie JR; Zhou G
J Clin Pathol; 2024 Apr; 77(5):330-337. PubMed ID: 36854623
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis.
Saluja TS; Ali M; Mishra P; Kumar V; Singh SK
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141
[TBL] [Abstract][Full Text] [Related]
14. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
15. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
16. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).
Srichinthu KK; Kumar GS; Prasad H; Rajmohan M; Anuthama K; Yoithapprabhunath TR
Indian J Dent Res; 2020; 31(5):738-742. PubMed ID: 33433512
[TBL] [Abstract][Full Text] [Related]
18. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
19. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.
Bates T; Kennedy M; Diajil A; Goodson M; Thomson P; Doran E; Farrimond H; Thavaraj S; Sloan P; Kist R; Robinson M
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):927-35. PubMed ID: 27197272
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
